Education Posters Resources General Info Supporters

Registration Options

Activity Date: 04/20/2016

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Wednesday, April 20, 2016, 8:00-9:00 a.m.
Joshua Roffman, MD, MMSc

Schizophrenia is a chronic illness characterized by positive symptoms, negative symptoms and impairments in neurocognition. Antipsychotics are the mainstay of treatment however we do not yet fully understand the pathophysiology of schizophrenia or if dopamine is a primary neurotransmitter or only as secondary messenger in the etiology of the illness. Environmental factors such as diet and vitamins have been shown to be associated with schizophrenia. This has been found during the illness but also during prenatal development when deficiencies in vitamins may play a key role in neurodevelopment. Growing evidence suggests that vitamin levels are lower in schizophrenia compared to healthy controls. Thus, vitamins may have a role in schizophrenia. Furthermore, accumulating evidence suggests that genetic polymorphisms or subgroup factors that may contribute to greater treatment response for symptoms in people with schizophrenia. This talk will focus on the role of vitamins in schizophrenia and will focus on understanding patient factors that may have a greater treatment response.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity. (sign in first)
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

This course will be provided at the CPNP 2016 Annual Meeting, April 17-20, 2016. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Review cross-sectional and epidemiologic studies of vitamin deficiency in schizophrenia.
  2. Understand how vitamin deficiency may contribute to the pathophysiology of schizophrenia.
  3. Discuss evidence for vitamin supplementation in schizophrenia and the role of genetics in treatment response.

Continuing Education Credit and Disclosures

Activity Date: 04/20/2016
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-023-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-023-L01-P (1.0 contact hours).